共病
慢性阻塞性肺病
医学
多发病率
重症监护医学
肺病
疾病
疾病管理
梅德林
物理疗法
精神科
内科学
政治学
法学
帕金森病
作者
Ioanna Tsiligianni,Epaminondas Kosmas,Thys van der Molen,Νikolaos Tzanakis
出处
期刊:Current Drug Targets
[Bentham Science]
日期:2013-01-01
卷期号:14 (2): 158-176
被引量:25
标识
DOI:10.2174/1389450111314020004
摘要
Chronic obstructive pulmonary disease is a public health problem that results in high morbidity, disability and mortality. Comorbidities are highly prevalent in COPD patients because of aging, common risk factors and pathways, rising mortality, and disability. In this review article we present the most prevalent co-morbidities in COPD patients, we face the issue of multimorbidity and discuss the practical management approach relevant to chest physicians and general practitioners. Issues on comorbidities management according to general guidelines as well as their implications for COPD are raised. The aim is to give clinicians an easy update with specific recommendations for each comorbidity. The implications of several medications used for comorbidities in COPD in terms of benefits, concerns, medication preference, medication avoidance and contraindications are also discussed.
科研通智能强力驱动
Strongly Powered by AbleSci AI